Worth reading
55In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
1085300
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Monthly exercise status of stock acquisition rights with an exercise price adjustment clause
発行・処分する株式数
Number of shares delivered during the month: 1,085,300 shares (all newly issued shares; transferred treasury shares: 0)
発行済株式総数
Exercise ratio subject to exercise restrictions: 1.88% (1,085,300 shares / 57,599,412 shares)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
Exercise price during the reporting month: ¥54.9–¥69.3. Details of the adjustment provisions and the lower limit: Not disclosed
Number of Stock Acquisition Rights
Total issued: approximately 390,000 Stock Acquisition Rights (calculated from the statement that 10,853 Stock Acquisition Rights represented 2.78% of the total issued, although the total issued itself was not disclosed). Unexercised balance at month-end: 379,147 Stock Acquisition Rights
Procedures under the Corporate Code of Conduct
Describes compliance with exercise restrictions under Article 434 of the Tokyo Stock Exchange Rules on Listing and the Japan Securities Dealers Association Rules Concerning the Handling of Third-Party Allotments and Other Matters
Most recent equity financing
Announced 14 September 2026: issuance through a third-party allotment of the 14th Stock Acquisition Rights (with an exercise price adjustment provision) and the 2nd Unsecured Bonds
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly exercise status of stock acquisition rights with an exercise price adjustment clause |
| Number of shares to be issued or disposed of | Number of shares delivered during the month: 1,085,300 shares (all newly issued shares; transferred treasury shares: 0) |
| Dilution Rate | Exercise ratio subject to exercise restrictions: 1.88% (1,085,300 shares / 57,599,412 shares) |
| Total number of issued shares | 57,599,412 shares (as of the end of the month preceding the reporting month, including 11,387 treasury shares) → Not disclosed |
| Exercise price | Exercise price during the reporting month: ¥54.9–¥69.3. Details of the adjustment provisions and the lower limit: Not disclosed |
| Number of Stock Acquisition Rights | Total issued: approximately 390,000 Stock Acquisition Rights (calculated from the statement that 10,853 Stock Acquisition Rights represented 2.78% of the total issued, although the total issued itself was not disclosed). Unexercised balance at month-end: 379,147 Stock Acquisition Rights |
| Procedures under the Corporate Code of Conduct | Describes compliance with exercise restrictions under Article 434 of the Tokyo Stock Exchange Rules on Listing and the Japan Securities Dealers Association Rules Concerning the Handling of Third-Party Allotments and Other Matters |
| Most recent equity financing | Announced 14 September 2026: issuance through a third-party allotment of the 14th Stock Acquisition Rights (with an exercise price adjustment provision) and the 2nd Unsecured Bonds |
Items this document does not state (20)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.